Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,224,509 | 1,223,195 | 1,196,980 | 1,162,801 | 1,102,321 |
| Cost of Goods | 507,290 | 507,667 | 504,199 | 515,867 | 502,261 |
| Gross Profit | 717,219 | 715,528 | 692,781 | 646,934 | 600,060 |
| Operating Expenses | 330,197 | 334,977 | 318,396 | 372,707 | 311,324 |
| Operating Income | 387,312 | 381,218 | 374,584 | 275,094 | 288,997 |
| Interest Expense | 1,661 | 5,920 | 11,026 | 13,805 | 14,957 |
| Other Income | -2,154 | -17,566 | 11,863 | -1,835 | -1,849 |
| Pre-tax Income | 383,497 | 357,732 | 375,421 | 259,454 | 272,191 |
| Income Tax | 72,142 | 65,495 | 74,929 | 50,654 | 52,769 |
| Net Income Continuous | 311,355 | 292,237 | 300,492 | 208,800 | 219,422 |
| Net Income | $311,355 | $292,237 | $300,492 | $208,800 | $219,422 |
| EPS Basic Total Ops | 2.12 | 1.99 | 2.04 | 1.42 | 1.49 |
| EPS Basic Continuous Ops | 2.12 | 1.99 | 2.04 | 1.42 | 1.49 |
| EPS Diluted Total Ops | 2.11 | 1.97 | 2.04 | 1.42 | 1.49 |
| EPS Diluted Continuous Ops | 2.11 | 1.98 | 2.04 | 1.42 | 1.49 |
| EPS Diluted Before Non-Recurring Items | 2.20 | 2.08 | 2.13 | 1.88 | 1.64 |
| EBITDA(a) | $441,022 | $435,973 | $429,226 | $328,464 | $342,439 |